<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain</title>
	<atom:link href="http://pharmainvestingnews.com/2009/06/nucyntatm-tapentadol-cii-immediate-release-tablets-now-available-for-relief-of-moderate-to-severe-acute-pain/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmainvestingnews.com/2009/06/nucyntatm-tapentadol-cii-immediate-release-tablets-now-available-for-relief-of-moderate-to-severe-acute-pain/</link>
	<description>Pharmaceutical Industry Investment News, Tips, Information and Reviews</description>
	<pubDate>Fri, 10 Sep 2010 12:30:34 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
	</channel>
</rss>
